|
|
||||||||
1 Departments of Medicine, 2 Pathology, and 3 Biochemistry, Boston University, Boston, Massachusetts 02118
| |
ABSTRACT |
|---|
|
|
|---|
Fat mass, adipocyte size and metabolic
responsiveness, and preadipocyte differentiation decrease between
middle and old age. We show that expression of CCAAT/enhancer binding
protein (C/EBP)-
, a key regulator of adipogenesis and fat cell
function, declined substantially with aging in differentiating
preadipocytes cultured under identical conditions from rats of various
ages. Overexpression of C/EBP
in preadipocytes cultured from old
rats restored capacity to differentiate into fat cells, indicating that
downstream differentiation-dependent genes maintain responsiveness to
regulators of adipogenesis. C/EBP
-expression also decreased with age
in fat tissue from three different depots and in isolated fat cells.
The overall level of C/EBP
, which modulates
C/EBP
-expression, did not change with age, but the truncated,
dominant-negative C/EBP
-liver inhibitory protein (LIP) isoform
increased in cultured preadipocytes and isolated fat cells. Overexpression of C/EBP
-LIP in preadipocytes from young rats impaired adipogenesis. C/EBP
, which acts with full-length C/EBP
to enhance adipogenesis, decreased with age. Thus processes intrinsic to adipose cells involving changes in C/EBP family members contribute to impaired adipogenesis and altered fat tissue function with aging.
These effects are potentially reversible.
preadipocytes; differentiation; C/EBP
; C/EBP
; c/EBP
| |
INTRODUCTION |
|---|
|
|
|---|
THE AGING PROCESS IS CHARACTERIZED by a decline in function of many physiological systems leading to a myriad of health problems in humans and other mammals. Among these is loss of fat tissue in very old individuals. Fat mass peaks by middle age or early old age and then declines substantially in advanced old age. Loss of fat tissue predisposes the elderly to chronic skin ulcers, disturbances of body temperature, and decreased energy reserves in the face of chronic illness (38, 57). Loss of fat tissue can also result in glucose intolerance (46, 51), potentially contributing to the paradoxical development of type II diabetes in very old, lean patients. Although fat mass declines, new fat cells are formed throughout the life span (5, 20, 39, 45), resulting in stable or increasing numbers of fat cells in fat tissue of old individuals (4, 31, 32, 36, 52, 61). Because fat cell responsiveness to lipolytic agents decreases with increasing age (16, 26, 31), declining body weight, fat mass, percent body fat, and fat cell size may be principally related to reduced capacity for lipid accumulation.
The capacity of preadipocytes to differentiate and accumulate lipid also declines with aging (17, 33, 36). Preadipocytes isolated from old rats and humans accumulate less lipid and have lower lipogenic enzyme activities when exposed to a variety of conditions that induce differentiation than preadipocytes from younger individuals, even after 3 wk in culture (14, 17, 33, 34). Consistent with their decreased capacity for differentiation, preadipocytes isolated from old rats exhibited decreased expression of several differentiation-dependent genes compared with preadipocytes cultured from young rats (34). These differences were not caused by inherent differences in basal expression of these genes in undifferentiated preadipocytes; rather, they reflect a difference in the extent of expression induced during the differentiation process. Thus whereas factors extrinsic to fat tissue (such as diet, activity, and hormonal milieu) likely contribute to declining fat mass during senescence, decreased capacity for lipid accumulation also involves age-related processes intrinsic to the individual preadipocytes and adipocytes in fat tissue.
We therefore hypothesized that the age-related decline in primary
preadipocyte differentiation and adipocyte function resulted from an
inability to express adequate levels of CCAAT/enhancer binding protein
(C/EBP)-
, an adipogenic transcription factor that regulates
adipogenesis. The importance of C/EBP
has been demonstrated in vivo,
because transgenic mice unable to express C/EBP
lack adipose tissue
(3, 46, 48, 55). In vitro, overexpression of C/EBP
is
sufficient to induce nonadipogenic cell lines to differentiate into
adipocytes, whereas overexpression of antisense C/EBP
inhibits differentiation (40). In addition to its
role in initiating preadipocyte differentiation, C/EBP
regulates
expression of key genes necessary for maintaining the fat cell
phenotype (11, 19, 60). Thus C/EBP
is a
"bottleneck" in the chain of events beginning with activation of
preadipocyte differentiation and ending with the appearance and
maintenance of functional fat cells.
Our studies establish that processes intrinsic to preadipocytes and fat
cells that involve alterations in expression of C/EBP family members
contribute to decreased adipogenesis with aging. We found that
C/EBP
-expression declined substantially with aging in
differentiating preadipocytes and fat tissue. Overexpressing C/EBP
restored adipogenesis of preadipocytes from old animals. The decline in
C/EBP
was related to increased levels of C/EBP
-liver inhibitory
protein (LIP), which interferes with expression of C/EBP
and other
adipogenic transcription factors (6, 8, 48, 53, 58, 60).
C/EBP
-LIP increased with aging both in cultured preadipocytes and in
fat tissue in vivo. Additionally, expression of C/EBP
, which acts
with full-length C/EBP
to enhance adipogenesis (58),
decreased with aging during early differentiation. These findings
clarify the mechanism of the age-related decline in preadipocyte
differentiation and shed light on processes responsible for decreases
in fat cell size and ability to assimilate lipids in the elderly.
| |
METHODS |
|---|
|
|
|---|
Preadipocyte isolation and culture.
Fischer 344 (median survival 26 mo; maximum survival 32 mo) and Brown
Norway rats (median survival 32 mo; maximum survival 43 mo) were
barrier-reared, specific pathogen-free, raised under constant
conditions, and inbred to reduce variability among animals in respects
other than their ages (10, 18, 50). The protocol was
approved by the Boston University Institutional Animal Care and Use
Committee. Separate groups of animals were used for each experiment.
Animals were autopsied, and those with evidence of pathology were
excluded. The epididymal or caudal portion [to exclude brown fat
(35)] of the perirenal depots of 3-, 17-, or 24- to
27-mo-old rats was removed, minced into fragments (~100 mm3), digested in 1 mg collagenase/ml Hanks' balanced salt
solution (pH 7.4) for 60 min at 37°C, and filtered through a 100-µm
nylon mesh (35). Isolated fat cells were prepared the same
way, except 3.5% bovine serum albumin was included in the digestion
solution. Digests were centrifuged for 10 min at 800 g.
Supernatants were used for fat cells. For preparing preadipocytes, the
pellets were resuspended in a basal medium (
-minimal essential
Eagle's medium containing 10% fetal bovine serum and antibiotics) and
plated at ~4 × 104 cells/cm2. After
12 h, a period during which no replication occurs
(14), the adherent preadipocytes were washed, trypsinized,
and replated at a density of 4 × 104
cells/cm2. We found that replating reduces macrophage and
mesothelial cell contamination and permits accurate plating densities.
This high plating density was used to ensure that cells from young and
old rats achieved confluence at the same time. Medium was changed every
2 days. We have previously demonstrated, using these methods, that
preadipocyte recoveries are similar among depots and age groups and
that our isolation procedures yield >90% pure preadipocyte populations, irrespective of age or fat depot origin (33).
Brown fat preadipocytes are not present in epididymal or perirenal
(caudal portion) cultures, because uncoupling protein 1 is not evident in perirenal or epididymal cultures after treatment with
-agonists but is observed in interscapular preadipocyte positive controls from
young rats (35). Confluent preadipocyte cultures were
differentiated in an enriched differentiation medium containing
10 µg/ml insulin, 10 mM glucose, 5 µg/ml Liposyn III 10%, and 20%
Nuserum. This medium was chosen over less-complex media because it
promotes more rapid and extensive differentiation (evidenced by lipid
accumulation) providing better sensitivity to detect age-related
decreases in expression of differentiation-dependent genes. Under the
conditions used in these experiments, >90% of cells in cultures from
3- and 24-mo-old animals had multiple small lipid inclusions by 48 h after addition of differentiation medium. However, more cells in the
cultures from 3-mo-old rats contained one to five large lipid
inclusions than cultures from 24-mo-old rats by 48 h [29 ± 4% vs. 16 ± 2% of cells in cultures 3- and 24-mo-old rats,
respectively (1.8-fold); n = 7; P < 0.005].
RNA analysis.
For RNA blot analyses, RNA was isolated from preadipocytes using the
guanidinium thiocyanate-phenol method (9). RNA integrity was verified using 2% denaturing agarose gels. Messenger RNA abundance was measured by RNA blot analysis, as described previously
(34). RNA was hybridized to a 1.5-kb fragment
complementary to C/EBP
(from plasmid ptet-o-C/EBP
), a 1.5-kb
fragment complementary to C/EBP
(from plasmid ptet-o-C/EBP
), a
450-bp fragment complementary to
-actin (from plasmid
pHF
A-3'UT-HF), or a 1.6-kb fragment complementary to 28S rRNA (from
clone pABE) (35). Preadipocyte mRNA levels
were measured densitometrically and adjusted for 28S rRNA levels in the
same lane on the same gel to correct for differences in RNA loading. We
have shown that 28S rRNA levels are the same in undifferentiated and
differentiated epididymal and perirenal preadipocytes when equal
numbers of cells are analyzed (34).
Protein analysis.
For protein analyses, cells were harvested and blotted as described
previously (44, 62). Membranes were probed with rabbit polyclonal antibodies to C/EBP
,
, or
mouse monoclonal
antibodies to C/EBP
(Santa Cruz Biotechnology; 14AA, C-19, C-22, and
H-7, respectively). Visualization of the binding of the horseradish peroxidase conjugated secondary antibody was performed by
chemiluminescence. Specificity of the interaction was assessed using
specific blocking peptide. Ten micrograms of protein were loaded in
each lane. Total protein contents (pg/cell) were 305 ± 32 and
310 ± 38 in undifferentiated and differentiated preadipocytes
from 3-mo-old rats, respectively, and 335 ± 39 and 333 ± 42 in undifferentiated and differentiated preadipocytes from 24-mo-old
rats (n = 16 in each group). Equal amounts of
protein from undifferentiated or differentiated preadipocytes from
young or old rats were loaded in parallel on the same gels. Amounts of
each protein loaded were selected so that results were in the linear
response range for that protein. Densitometric results were expressed
as a percentage of total optical density within each gel and were
normalized to reflect differences in cellular protein content.
DNA transfection.
Preadipocytes from 24-mo-old rats were cotransfected with pMT2rC/EBP
and pMSV-
gal (Invitrogen) at a molar ratio of 5:1 (transcription factor/reporter construct) using the calcium phosphate precipitation method without glycerol shock treatment to ensure that transfected cells detected by staining for
-galactosidase (
gal) would also be
expressing C/EBP
. Approximately 15% of transfected cells were positive for
gal. Increased C/EBP
-expression in transfected cells
was verified by Western immunoanalysis. Transfection efficiency was not
affected by aging. Mock-control cells were transfected with pMSV-
gal
and pMT2xHGh that consists of the adenovirus major late promoter fused
to a reverse-orientation human growth hormone construct of the same
size as pMT2rC/EBP
. After 48 h of culture in differentiation
medium, cultures were fixed in 3% formaldehyde and stained with the
chromatographic
gal substrate x-gal to identify transfected cells
(49). Observers unaware of the origin of the cells
assessed extent of differentiation by examining transfected cells for
the presence of doubly refractile lipid inclusions using low-power
phase-contrast microscopy (33, 56). The lipid nature of
these inclusions was confirmed by staining with oil red O. The
proportion of transfected cells containing such inclusions was compared
with that of parallel mock-control cultures. For C/EBP
-LIP
transfection experiments, we used the probe CMV-LIP, kindly provided by
Dr. U. Schibler (12), and a transfection and analysis
strategy analogous to that described above for C/EBP
except that
transfectants from 3-mo-old animals were exposed to differentiation
medium for 72 h. Increased C/EBP
-LIP expression in transfected
cells was verified by Western immunoanalysis.
Statistical analysis. Results are means ± SE, and significance determination was by paired t-tests or ANOVA as appropriate (28, 29). In transfection experiments, comparisons of numbers of transfectants containing lipid inclusions to mock-transfected cells were made by logistic regression analysis, with P values determined from log likelihood ratios (37).
| |
RESULTS |
|---|
|
|
|---|
Expression of C/EBP
declines with aging.
To determine whether altered C/EBP
-expression contributes to
the age-related decline in the intrinsic capacity of preadipocytes to
differentiate, we measured C/EBP
-mRNA levels in undifferentiated and
differentiated preadipocytes cultured from perirenal fat depots of
young (3 mo), middle-aged (17 mo), and old (24 mo) Fischer 344 rats.
Donor age had no effect on C/EBP
-mRNA levels in primary undifferentiated preadipocytes (Fig. 1).
However, we observed significant blunting of differentiation-related
induction of C/EBP
-mRNA abundance with increasing donor age.
C/EBP
-mRNA levels in differentiating cells declined progressively
through the life span so that C/EBP
-mRNA abundance was 7.5-fold
higher in cells from young compared with old animals (P < 0.01, n = 5). A similar age-related decline in C/EBP
-mRNA induction was observed in each of three experiments (data
not shown) in preadipocytes cultured from barrier-reared Brown Norway
rats that differed from Fischer 344 rats in several respects
(42). Use of a differentiation-inducing medium of
composition distinct from that used in the above experiments
(34) resulted in the same age-related decline in
C/EBP
-mRNA induction (data not shown). Thus a substantial decrease
in C/EBP
-mRNA induction during adipogenesis occurs throughout the
lifespan, and this change results from events intrinsic to primary
preadipocytes.
|
-induction during
preadipocyte differentiation in primary preadipocytes from young and
old rats, because age-related differences in C/EBP
-abundance could
reflect differences in the time course of C/EBP
-induction. Increases
in C/EBP
-protein were evident by 4 h in differentiating preadipocytes from both age groups and achieved peak levels within 24 h that were sustained at least 72 h (Fig.
2). Within 8 h after initiation of
differentiation, the induced level of C/EBP
-protein was
significantly greater in differentiating preadipocytes isolated from
young compared with old animals (Fig. 3;
2.4 ± 0.1-fold; P < 0.00001, n = 6; paired t-test). Similar results were found in epididymal
preadipocytes (data not shown). C/EBP
-mRNA is alternatively translated into 42- and 30-kDa protein isoforms, with the 42-kDa isoform being more effective at promoting differentiation and the
replicative arrest that accompanies differentiation than the 30-kDa
isoform (41). Although total C/EBP
-expression declined with aging, relative expression of the two C/EBP
-protein isoforms remained unchanged. Densities of the 42-kDa isoform in cells from 3- and 24-mo-old rats were 2.0 ± 0.3 and 2.0 ± 0.2 times
greater than the 30-kDa isoform, respectively (n = 6).
Therefore, the age-related decline in C/EBP
-mRNA was 1)
mirrored by concomitant changes in C/EBP
-protein abundance,
2) evident early in the differentiation program, and
3) reflective of overall diminished C/EBP
-levels rather
than a delayed response to differentiation inducers or alterations in
the proportions of C/EBP
-protein isoforms.
|
|
-expression
during preadipocyte differentiation is maintained in fat cells in vivo,
we measured C/EBP
-mRNA abundance in collagenase-isolated inguinal
fat cells from young, middle-aged, and old Brown Norway rats. We
observed an age-related decline in isolated fat cell C/EBP
-mRNA
abundance similar to that in differentiating cultured preadipocytes
(Fig. 4A). An analogous, progressive,
age-related decline in total C/EBP
-protein levels was also observed
in epididymal, perirenal, and inguinal fat tissue from young and old
Fischer 344 rats (2.3 ± 0.6-fold; n = 3 young and
3 old rats, 3 sites; P < 0.005; ANOVA), with no change
in relative expression of the 42- and 30-kDa isoforms (Fig.
4B). Decreased C/EBP
-protein abundance was also apparent
in adipocytes isolated from the epididymal depots of 27- compared with
3-mo-old Brown Norway rats (data not shown). Thus the decline in
C/EBP
-expression with aging in differentiating cultured
preadipocytes is reflected in fat cells in vivo, occurs in different
rat strains, and is an intrinsic feature of fat cells from all depots
tested.
|
-expression. To determine whether augmenting C/EBP
-expression in preadipocytes from old animals can
restore capacity to accumulate lipid, we transiently transfected epididymal preadipocytes from 24-mo-old rats with a rat-specific C/EBP
-expression vector, pMT2rC/EBP
(Fig.
5). A constitutively, highly expressed
gal reporter construct pMSV-
gal was cotransfected at a molar
ratio of 5:1 (transcription factor/reporter construct) to allow
identification of transfected cells. After exposure to differentiation-inducing medium for 48 h, lipid accumulation in
gal-expressing C/EBP
-transfectants was compared with that in
gal-expressing mock-transfected cells. Despite the relatively brief
exposure of transfected preadipocytes from old donors to differentiation-inducing medium, C/EBP
-overexpression more than quadrupled the number of
gal-positive transfectants from old animals
that accumulated lipid droplets visible by low-power microscopy [odds
ratio 4.1-fold vs. mock-transfected cells (95% confidence limits
2.4-6.9); P < 0.00001; n = 4 rats, 100 C/EBP
- and 100 mock-transfected cells/rat]. Thus,
although C/EBP
-expression during differentiation is blunted with
aging, the ability of downstream, differentiation-dependent target
genes to respond to transiently overexpressed C/EBP
is retained.
|
C/EBP
-LIP expression increases with aging.
In adipogenic cell lines, expression of C/EBP
and other adipogenic
transcription factors is influenced by C/EBP
, a transcription factor
that is expressed earlier during the differentiation program (6,
8, 48, 53, 58, 60). C/EBP
-mRNA can be alternatively translated into C/EBP
-liver activating protein (LAP) isoforms of
~40 kDa that promote differentiation or the dominant negative 19-kDa
C/EBP
-LIP isoform that inhibits the adipogenic program in
preadipocyte cell lines by binding to and inactivating adipogenic C/EBP
isoforms (i.e., C/EBP
, C/EBP
-LAP, CEBP
) (12, 60). Therefore, even modest decreases in the ratio of LAP to LIP
could inhibit differentiation (12, 60).
-mRNA (Fig.
6). The total amount of C/EBP
-protein
measured by densitometry was also not affected by age [ratio of total
C/EBP
-protein in preconfluent preadipocytes from 3-mo-old to
24-mo-old animals = 0.98 ± 0.20 and in preadipocytes treated
with differentiation-inducing medium for 4 h, 0.99 ± 0.09 (Fig. 7)]. LAP/LIP ratios were similar in preconfluent preadipocytes from young and old animals
{[LAP/LIP]young/[LAP/LIP]old = 1.0 ± 0.3, P = not significant}. However,
4 h after initiating the differentiation program, the ratio of LAP
to LIP in preadipocytes from young rats was twice that in cells from
old animals
{[LAP/LIP]young/[LAP/ LIP]old = 2.0 ± 0.4, P < 0.02; n = 10}.
|
|
-LIP isoform in differentiating preadipocytes was
observed both in whole fat tissue and collagenase-isolated fat cells
from epididymal, inguinal, and perirenal fat depots (Fig.
8). Thus the increase in inhibitory
C/EBP
-LIP expression with aging is a common feature of both primary
preadipocytes and fat cells in all depots tested. A 14-kDa
C/EBP
-isoform, which may be a proteolytic cleavage product of
C/EBP
(1), was found in whole fat tissue but not in
cultured preadipocytes. However, abundance of the 14-kDa isoform was
not affected significantly by aging (abundance in young/old = 1.03 ± 0.18; P = 0.75 by ANOVA; n = 3 depots in 3 animals).
|
-LIP isoform expression likely contributes to
decreasing adipogenesis with aging. To test this prediction, we
transiently transfected a truncated C/EBP
-vector, CMV-LIP, that
overexpresses only C/EBP
-LIP (12) into perirenal
preadipocytes isolated from young animals. These cells normally
differentiate much more extensively than cells from old animals or
cells isolated from other fat depots of young animals
(33). The
gal-reporter construct pMSV-
gal was
cotransfected at a 5:1 molar ratio (transcription factor/reporter
construct) to allow identification of transfected cells. After exposure
to differentiation-inducing medium for 72 h, lipid accumulation in
gal-expressing C/EBP
-LIP transfectants was compared with that in
mock-transfected
gal-expressing cells in parallel cultures.
C/EBP
-LIP overexpression caused a 90% reduction in the number of
gal-positive transfectants from young animals that accumulated
visible lipid droplets [odds ratio 0.09 vs. mock-transfected cells
(95% confidence limits 0.03-0.27); P < 0.0001;
n = 4 rats, 100 LIP- and 100 mock-transfected
cells/rat]. Thus C/EBP
-LIP expression inhibits adipogenesis in
young primary rat preadipocytes as occurs in cell lines
(60), supporting our contention that increasing
C/EBP
-LIP expression with aging contributes to decreased capacity
for adipogenesis in primary preadipocytes.
C/EBP
-expression declines with aging.
In cell lines, C/EBP
acts in concert with full-length C/EBP
early
during differentiation to augment adipogenesis (58). We
also observed a transient increase in C/EBP
-abundance early during
primary preadipocyte differentiation that peaked at about 4 h
(data not shown). A decline in C/EBP
-protein abundance with aging
was found 4 h after induction of differentiation in preadipocytes from 3- compared with 24-mo-old rats (Fig.
9; C/EBP
in young/old = 1.7 ± 0.3; n = 5; P < 0.05; paired
t-test). Thus decreased induction of
C/EBP
-expression early during differentiation may, together with
increased C/EBP
-LIP, contribute to impaired adipogenesis with aging.
|
| |
DISCUSSION |
|---|
|
|
|---|
Most cell dynamic research on aging has been focused on effects of aging on cell replication. Less is known about effects of aging on the capacity of cells to acquire specialized function through differentiation. However, there may be a general tendency for aging to be associated with impaired capacity for differentiation. Besides the age-related impairment in preadipocyte differentiation, declines have been documented in adrenocortical precursor, cultured keratinocyte, and intestinal crypt cell differentiation (21, 22, 25, 27, 47). Until our work in preadipocytes, the mechanisms responsible for this impairment in differentiation with aging were not well understood.
Our work in primary preadipocytes shows that changes in
expression of the adipogenic regulators C/EBP
, C/EBP
-LIP, and
C/EBP
contribute to blunted differentiation with aging. These
orchestrated changes involve increases as well as decreases in
expression of key adipogenic regulators both at the mRNA and protein
levels, leading to decreased adipogenesis. For example, the
differentiation-dependent profile of C/EBP
-mRNA expression declined
with age, whereas that of C/EBP
did not. Conversely, the relative
abundance the antiadipogenic C/EBP
-LIP-protein isoform increased
with donor age, whereas that of C/EBP
-isoforms was unchanged.
Restoration of C/EBP
-levels in preadipocytes from old donors by
transient transfection allowed them to complete the differentiation
program, suggesting that the primary defect was the inability to
maintain adequate levels of this important adipogenic regulator.
We anticipated that changes in adipogenic transcription factor
expression would impair not only the ability of preadipocytes to
differentiate, but might also exhibit age-related changes in expression
in the fat cells that develop from them. This was, in fact, what we
observed. Reduced abundance of C/EBP
- and elevated C/EBP
-LIP
expression were found both in cultured differentiating preadipocytes
and in fat cells in vivo, indicating that our findings in vitro are
relevant in vivo. These changes in adipogenic transcription factor
expression would be anticipated to impair not only preadipocyte differentiation, but also to influence the function of the fat cells
that develop from them. For example, in addition to reduced fat cell
size, blunted C/EBP
-expression in adipocytes can contribute to
impaired glucose tolerance through effects on Glut4 expression (15), among other mechanisms. We also found that abundance
of adipocyte lipid binding protein (aP2), the expression of which is
induced by C/EBP
, is lower in fat cells from old than from young
rats (7). Furthermore, decreased C/EBP
- in concert with increased C/EBP
-LIP expression may be a general aging phenomenon in
organs involved in lipid metabolism. For example, C/EBP
-abundance declines with age in freshly isolated whole mouse liver tissue and, after treatment with lipopolysaccharide, more C/EBP
-LIP is
expressed in this tissue in old than in young mice (24).
The age-related increase in preadipocyte C/EBP
-LIP expression is
triggered by events during initiation of differentiation, because
expression of C/EBP
-LIP relative to C/EBP
-LAP was the same in
undifferentiated preadipocytes from young and old animals but was
higher in preadipocytes from old animals within 4 h of exposure to
enriched medium. As cells become differentiated fully, the effect of
aging on C/EBP
-LIP expression is increasingly evident, so that
C/EBP
-LIP protein was very abundant in fat tissue from old animals
and not detectable in fat tissue from young animals. This implies that
abundance of the C/EBP
-LIP isoform relative to C/EBP
-LAP is regulated.
Two potential mechanisms responsible for the relative abundance of
C/EBP
-LIP and C/EBP
-LAP have been proposed. The first involves
RNA processing. There are two potential translation initiation sites in
the C/EBP
-mRNA that are upstream and in frame of the site from
which C/EBP
-LIP is translated. C/EBP
-LIP may be produced because
of leaky ribosomal scanning resulting in bypassing these sites in favor
of the C/EBP
-LIP initiation site (12). This alternative
translation process appears to be regulated. An RNA binding protein,
CUG triplet repeat binding protein, may be involved in switching among
translation initiation sites to produce C/EBP
-isoforms (54). The second potential mechanism proposed to regulate
C/EBP
-isoform abundance is that proteases, possibly caspases,
cleave full-length C/EBP
-protein, as can occur in macrophages and
liver tissue (1, 2). Proteases result in production of 19- and 14-kDa carboxy terminal C/EBP
-isoforms, the 14-kDa isoform being
a prominent product (1). However, we did not detect the
14-kDa isoform in any preadipocyte preparation, although the antibody
used would have detected such a product. Whereas we did find a 14-kDa
C/EBP
-isoform in whole fat tissue preparations, its abundance was
not affected significantly by aging in the same experiments as those in
which the 19-kDa isoform increased. Thus the age-related increase in C/EBP
-LIP expression we found in adipose tissue is very unlikely to
be a result of artifactual proteolytic cleavage during protein extraction. Whatever the responsible mechanism, it is regulated both by
aging and by differentiation, and the age-related increase in
C/EBP
-LIP expression results from processes intrinsic to adipose cells.
Besides the C/EBP family members, PPAR
is another transcription
factor important in preadipocyte differentiation (3, 48). Expression of C/EBP
or of C/EBP
and C/EBP
together augments PPAR
-expression in cell lines (58, 59). In addition to
inhibiting activity and expression of C/EBP
, C/EBP
-LIP causes
reduced PPAR
-expression (S. Farmer, personal communication). Because
expression of C/EBP
-LIP increases with age and that of C/EBP
and
decreases, an age-related decline in PPAR
-expression would be
anticipated to occur in fat. Indeed, an age-related decline in
PPAR
-mRNA abundance has been observed in subcutaneous whole fat
tissue from monkeys (23). Thus decreased expression of
PPAR
may also contribute to decreased adipogenesis with aging.
Perspectives
Perhaps decreasing adipogenic transcription factor expression with aging serves a protective function. Through middle age, the combination of increasing fat cell size and number contributes to enlargement of fat mass. Because fat cell turnover occurs slowly (in excess of 140 days in the rat), changes in fat cell characteristics in old age necessarily reflect alterations that occur in preadipocyte function earlier in life (7, 32, 39). Because preadipocyte and fat cell numbers remain stable or increase in old age, if the age-related decline in adipogenic transcription factor expression were not to occur, massive obesity could ensue in later life. Indeed, reduced preadipocyte differentiation capacity may account for the stable or increasing number of preadipocytes in fat depots with aging, despite declining preadipocyte replicative potential (33), and reduced C/EBP
-expression in fat cells may contribute to the
decrease in fat cell size that occurs between middle and old age.
Our findings are consistent with the hypothesis that the wide array of phenotypic effects characteristic of aging result from its influence on expression of specific regulatory proteins at early points in pathways controlling expression of many downstream genes (13, 23, 30, 43). Although intervening to alter expression of such proteins may not affect the underlying process causing senescence itself, our findings demonstrate the feasibility of restoring specific functions to senescent cells through such interventions.
| |
ACKNOWLEDGEMENTS |
|---|
The authors are grateful to T. Lash for statistical advice.
| |
FOOTNOTES |
|---|
* I. Karagiannides and T. Tchkonia contributed equally to this work.
This work was supported by National Institutes of Health Grants AG-13925, DK-46200, DK-44269, and HL-56104 and American Heart Association Grant-in-Aid 96011700.
Present addresses: D. E. Dobson, Dept. of Molecular Microbiology, Washington Univ., St. Louis, MO 63110; C. M. Steppan, Dept. of Medicine, Univ. of Pennsylvania, Philadelphia, PA 19104; P. Cummins, Massachusetts Dept. of Public Health, Boston, Massachusetts 02108; and M. Hadzopoulou-Cladaras, Dept. of Biology, Aristotle Univ. of Thessaloniki, Thessaloniki, Greece.
Address for reprint requests and other correspondence: J. L. Kirkland, Boston Univ., 88 E. Newton St., F435, Boston, MA 02118.
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 20 September 2000; accepted in final form 18 January 2001.
| |
REFERENCES |
|---|
|
|
|---|
1.
Baer, M,
and
Johnson P.
Generation of truncated C/EBP
isoforms by in vitro proteolysis.
J Biol Chem.
23:
26582-26590,
2000.
2.
Baer, M,
Williams S,
Dillner A,
Schwartz R,
and
Johnson P.
Autocrine signals control CCAAT/enhancer binding protein beta expression, localization, and activity in macrophages.
Blood
92:
4353-4365,
1998
3.
Barak, Y,
Nelson MC,
Ong ES,
Jones YZ,
Ruiz-Lozano P,
Chien KR,
Koder A,
and
Evans RM.
PPAR
is required for placental, cardiac and adipose tissue development.
Mol Cell
4:
585-595,
1999[Web of Science][Medline].
4.
Bertrand, HA,
Lynd FR,
and
Masoro EJ.
Changes in adipose mass and cellularity through the adult life of rats fed ad libitum or a life-prolonging restricted diet.
J Gerontol B Psychol Sci Soc Sci
35:
827-835,
1980.
5.
Bertrand, HA,
and
Masoro EJ.
Increasing adipocyte number as the basis for perirenal depot growth in adult rats.
Science
201:
1234-1235,
1978
6.
Cao, Z,
Umek RM,
and
McKnight SL.
Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells.
Genes Dev
5:
1538-1552,
1991
7.
Caserta, F,
Tchkonia T,
Civelek V,
Prentki M,
Brown N,
McGarry J,
Forse R,
Corkey B,
Hamilton J,
and
Kirkland J.
Fat depot origin affects fatty acid handling in cultured rat and human preadipocytes.
Am J Physiol Endocrinol Metab
280:
E238-E247,
2001
8.
Chawla, A,
and
Lazar MA.
Peroxisome proliferator and retinoid signaling pathways co-regulate preadipocyte phenotype and survival.
Proc Natl Acad Sci USA
91:
1786-1790,
1994
9.
Chomczynski, P,
and
Sacchi N.
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
Anal Biochem
162:
156-159,
1987[Web of Science][Medline].
10.
Christy, RJ,
Kaestner KH,
Geiman DE,
and
Lane MD.
CCAAT/enhancer binding protein gene promoter: binding of nuclear factors during differentiation of 3T3-L1 preadipocytes.
Proc Natl Acad Sci USA
88:
2593-2597,
1991
11.
Christy, RJ,
Yang VW,
Ntambi JM,
Geiman DE,
Landschulz WH,
Friedman AD,
Nakabeppu Y,
Kelly TJ,
and
Lane MD.
Differentiation-induced gene expression in 3T3-L1 preadipocytes: CCAAT/enhancer binding protein interacts with and activates the promoters of two adipocyte-specific genes.
Genes Dev
3:
1323-1335,
1989
12.
Descombes, P,
and
Schibler U.
A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA.
Cell
67:
569-579,
1991[Web of Science][Medline].
13.
Dimri, GP,
and
Campisi J.
Altered profile of transcription factor binding activities during cellular senescence.
Exp Cell Res
212:
132-140,
1994[Web of Science][Medline].
14.
Djian, P,
Roncari DAK,
and
Hollenberg CH.
Influence of anatomic site and age on the replication and differentiation of rat adipocyte precursors in culture.
J Clin Invest
72:
1200-1208,
1983.
15.
El Jack, AK,
Hamm JK,
Pilch PF,
and
Farmer SR.
Reconstitution of insulin-sensitive glucose transport in fibroblasts requires expression of both PPAR
and C/EBP
.
J Biol Chem
274:
7946-7951,
1999
16.
Gregerman, RI.
Aging and hormone sensitive lipolysis: reconciling the literature.
J Gerontol B Psychol Sci Soc Sci
49:
B135-B139,
1994.
17.
Hauner, H,
Entenmann G,
Wabitsch M,
Gaillard D,
and
Ailhaud G.
Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium.
J Clin Invest
84:
1663-1670,
1989.
18.
Hazzard, DG,
and
Soban J.
Studies of aging using genetically defined rodents: a bibliography.
Exp Aging Res
14:
59-81,
1988[Web of Science][Medline].
19.
Hollenberg, AN,
Susulic VS,
Madura JP,
Zhang B,
Moller DE,
Tontonoz P,
Sarraf P,
Spiegelman BM,
and
Lowell BB.
Functional antagonism between CCAAT/enhancer binding protein-
and peroxisome proliferator-activated receptor-
on the leptin promoter.
J Biol Chem
272:
5283-5290,
1997
20.
Hollenberg, CH,
and
Vost A.
Regulation of DNA synthesis in fat cells and stromal elements from rat adipose tissue.
J Clin Invest
47:
2485-2498,
1968[Web of Science].
21.
Holt, PR,
Tierney AR,
and
Kotler DP.
Delayed enzyme expression: a defect of aging rat gut.
Gastroenterology
89:
1026-1034,
1985[Web of Science][Medline].
22.
Hornsby, PJ,
Ryan RF,
and
Cheng CY.
Replicative senescence and differentiated gene expression in cultured adrenocortical cells.
Exp Gerontol
24:
539-558,
1989[Web of Science][Medline].
23.
Hotta, K,
Bodkin NL,
Gustafson TA,
Yoshioka S,
Ortmeyer HK,
and
Hansen BC.
Age-related adipose tissue mRNA expression of ADD1/SREBP1, PPAR
, lipoprotein lipase, and GLUT4 glucose transporter in rhesus monkeys.
J Gerontol
54A:
B183-B188,
1999.
24.
Hsieh, C,
Xiong W,
Xie Q,
Rabek J,
Scott S,
Reisner P,
Kuminger D,
and
Papaconstantinou J.
Effects of age on the posttranscriptional regulation of CCAAT/enhancer binding protein alpha and CCAAT/enhancer binding protein beta isoform synthesis in control and LPS-treated livers.
Mol Biol Cell
9:
1479-1494,
1998
25.
Ibrahim, M,
Upreti RK,
and
Kidwai AM.
Calpain from rat intestinal epithelial cells: age-dependent dynamics during cell differentiation.
Mol Cell Biochem
131:
49-59,
1994[Web of Science][Medline].
26.
Jarvinen, HY,
Kiviluoto T,
and
Nikkila EA.
Insulin binding and action in adipocytes in vitro in relation to insulin action in vivo in young and middle-aged subjects.
Acta Endocrinol
113:
88-92,
1986.
27.
Jensen, PK,
Norgard JO,
and
Bolund L.
Lateral growth and terminal differentiation during repeated epidermal regeneration in vitro. Age dependence and modulation by cholera toxin.
Virchows Arch
62:
189-198,
1992.
28.
Kachigan, SK.
Statistical Analysis. New York: Radius, 1986.
29.
Keppel, G.
Design and Analysis: A Researcher's Handbook. Englewood Cliffs, NJ: Prentice-Hall, 1973.
30.
Kirkland, JL.
Commentary: aging, differentiation-dependent gene expression, and fat cell function.
J Gerontol
54A:
B198-B190,
1999.
31.
Kirkland, JL,
and
Dax EM.
Adipose hormone responsiveness and aging in the rat.
J Am Geriatr Soc
32:
219-228,
1984[Web of Science][Medline].
32.
Kirkland, JL,
and
Dobson DE.
Preadipocyte function and aging: links between age-related changes in cell dynamics and altered fat cell function.
J Am Geriatr Soc
45:
959-967,
1997[Web of Science][Medline].
33.
Kirkland, JL,
Hollenberg CH,
and
Gillon WS.
Age, anatomic site, and the replication and differentiation of adipocyte precursors.
Am J Physiol Cell Physiol
258:
C206-C210,
1990
34.
Kirkland, JL,
Hollenberg CH,
and
Gillon WS.
Ageing, differentiation, and gene expression in rat epididymal preadipocytes.
Biochem Cell Biol
71:
556-561,
1993[Web of Science][Medline].
35.
Kirkland, JL,
Hollenberg CH,
and
Gillon WS.
Effects of fat depot site on differentiation-dependent gene expression in rat preadipocytes.
Int J Obes
20, Suppl3:
S102-S107,
1996[Web of Science].
36.
Kirkland, JL,
Hollenberg CH,
Kindler S,
and
Gillon WS.
Effects of age and anatomic site on preadipocyte number in rat fat depots.
J Gerontol B Psychol Sci Soc Sci
49:
B31-B35,
1994.
37.
Kleinbaum, D,
Kupper L,
and
Muller K.
Applied Regression Analysis and Other Multivariate Methods. Belmont, CA: Duxbury, 1998.
38.
Klipstein-Grobusch, K,
Reilly JJ,
and
Potter J.
Energy intake and expenditure in elderly patients admitted to hospital with acute illness.
Br J Nutr
73:
323-334,
1995[Web of Science][Medline].
39.
Klyde, BJ,
and
Hirsch J.
Isotopic labeling of DNA in rat adipose tissue: evidence for proliferating cells associated with mature adipocytes.
J Lipid Res
20:
691-704,
1979
40.
Lin, FT,
and
Lane MD.
Antisense CCAAT/enhancer binding protein RNA suppresses co-ordinate gene expression and triglyceride accumulation during differentiation of 3T3-L1 preadipocytes.
Genes Dev
6:
533-544,
1992
41.
Lin, FT,
MacDougald OA,
Diehl AM,
and
Lane MD.
A 30-kDa alternative translation product of the CCAAT/enhancer binding protein alpha message: transcriptional activator lacking antimitotic activity.
Proc Natl Acad Sci USA
90:
9606-9610,
1993
42.
Lipman, RD,
Chrisp CE,
Hazzard DG,
and
Bronson RT.
Pathologic characteristics of Brown Norway X Fischer 344, and Fischer 344 X Brown Norway rats in relation to age.
J Gerontol
51A:
B54-B59,
1996[Web of Science].
43.
Ly, DH,
Lockhart DJ,
Lerner RA,
and
Schultz PG.
Mitotic misregulation and human aging.
Science
287:
2486-2492,
2000
44.
Majumdar, S.
Protein kinase C isotypes and signaling in neutrophils.
J Biol Chem
266:
9285-9294,
1991
45.
Miller, WH,
Faust IM,
and
Hirsch J.
Demonstration of de novo production of adipocytes in adult rats by biochemical and radioautographic techniques.
J Lipid Res
25:
336-347,
1984[Abstract].
46.
Moitra, I,
Mason MM,
Olive M,
Krylov D,
Gavrilova O,
Marcus-Samuels B,
Feigenbaum L,
Lee E,
Aoyama T,
Eckhaus M,
Reitman ML,
and
Vinson C.
Life without white fat: a transgenic mouse.
Genes Dev
12:
3168-3181,
1998
47.
Norsgaard, H,
Clark BF,
and
Rattan SI.
Distinction between differentiation and senescence and the absence of increased apoptosis in human keratinocytes undergoing cellular aging in vitro.
Exp Gerontol
31:
563-570,
1996[Web of Science][Medline].
48.
Rosen, ED,
Sarraf P,
Troy AE,
Bradwin G,
Moore K,
Milstone DS,
Spiegelman BM,
and
Mortensen RM.
PPAR
is required for the differentiation of adipose tissue in vivo and in vitro.
Mol Cell
4:
611-617,
1999[Web of Science][Medline].
49.
Sanes, JR,
Rubenstein JLR,
and
Nicolas JF.
Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos.
EMBO J
5:
3133-3142,
1986[Web of Science][Medline].
50.
Shimokawa, I,
Higami Y,
Hubbard GB,
McMahan CA,
Masoro EJ,
and
Yu BP.
Diet and the suitability of the male Fischer 344 rat as a model for aging research.
J Gerontol B Psychol Sci Soc Sci
48:
B27-B32,
1993.
51.
Shimomura, I,
Hammer RE,
Richardson JA,
Ikemoto S,
Bashmakov Y,
Goldstein JL,
and
Brown MS.
Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy.
Genes Dev
12:
3182-3194,
1998
52.
Silver, AJ,
Guillen CP,
and
Kahl MJ.
Effect of aging on body fat.
J Am Geriatr Soc
41:
211-213,
1993[Web of Science][Medline].
53.
Spiegelman, BM,
and
Flier JS.
Adipogenesis and obesity: rounding out the big picture.
Cell
87:
377-389,
1996[Web of Science][Medline].
54.
Timchenko, N,
Welm A,
Lu X,
and
Timchenko L.
CUG repeat binding protein (CUGBP1) interacts with the 5' region of C/EBP
mRNA and regulates translation of C/EBP
isoforms.
Nucleic Acids Res
27:
4517-4525,
1999
55.
Wang, N,
Finegold MJ,
Bradley A,
Ou CN,
Abdelsayed SV,
Wilde MD,
Taylor LR,
Wilson DR,
and
Darlington GJ.
Impaired energy homeostasis in C/EBP
knockout mice.
Science
269:
1108-1112,
1995
56.
Wang, H,
Kirkland JL,
and
Hollenberg CH.
Varying capacities for replication of rat adipocyte precursor clones and adipose tissue growth.
J Clin Invest
83:
1741-1746,
1989.
57.
Waters, JM,
and
Bessey PQ.
Critical care for the elderly patient.
Surg Clin North Am
74:
187-197,
1994[Web of Science][Medline].
58.
Wu, Z,
Bucher NLR,
and
Farmer SR.
Induction of PPAR
during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBP
, C/EBP
and glucocorticoids.
Mol Cell Biol
16:
5964-5973,
1996[Abstract].
59.
Wu, Z,
Rosen ED,
Brun R,
Hauser S,
Adelmant G,
Troy AE,
McKeon C,
Darlington GJ,
and
Spiegelman BM.
Cross-regulation of C/EBP
and PPAR
controls the transcriptional pathway of adipogenesis and insulin sensitivity.
Mol Cell
3:
151-158,
1999[Web of Science][Medline].
60.
Yeh, WC,
Cao M,
Classon M,
and
McKnight SL.
Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins.
Genes Dev
9:
168-181,
1995
61.
Yu, BP,
Masoro EJ,
and
Murata I.
Lifespan study of SPF Fischer 344 male rats fed ad libitum or restricted diets: longevity, growth, lean body mass and disease.
J Gerontol B Psychol Sci Soc Sci
37:
130-141,
1982.
62.
Zapata, JM,
Takahashi R,
Salvesen GS,
and
Reed JC.
Granzyme release and caspase activation in activated human T-lymphocytes.
J Biol Chem
273:
6916-6920,
1998
This article has been cited by other articles:
![]() |
D. Wu and S. N. Meydani Age-associated changes in immune and inflammatory responses: impact of vitamin E intervention J. Leukoc. Biol., October 1, 2008; 84(4): 900 - 914. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tchkonia, T. Pirtskhalava, T. Thomou, M. J. Cartwright, B. Wise, I. Karagiannides, A. Shpilman, T. L. Lash, J. D. Becherer, and J. L. Kirkland Increased TNF{alpha} and CCAAT/enhancer-binding protein homologous protein with aging predispose preadipocytes to resist adipogenesis Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1810 - E1819. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Guo, T. Pirtskhalava, T. Tchkonia, W. Xie, T. Thomou, J. Han, T. Wang, S. Wong, A. Cartwright, F. G. Hegardt, et al. Aging results in paradoxical susceptibility of fat cell progenitors to lipotoxicity Am J Physiol Endocrinol Metab, April 1, 2007; 292(4): E1041 - E1051. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Sengenes, A. Zakaroff-Girard, A. Moulin, M. Berlan, A. Bouloumie, M. Lafontan, and J. Galitzky Natriuretic peptide-dependent lipolysis in fat cells is a primate specificity Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2002; 283(1): R257 - R265. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tchkonia, N. Giorgadze, T. Pirtskhalava, Y. Tchoukalova, I. Karagiannides, R. A. Forse, M. DePonte, M. Stevenson, W. Guo, J. Han, et al. Fat depot origin affects adipogenesis in primary cultured and cloned human preadipocytes Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2002; 282(5): R1286 - R1296. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. F. DiBona Neuropeptide Y Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2002; 282(3): R635 - R636. [Full Text] [PDF] |
||||
![]() |
P. B. Persson Aging Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2002; 282(1): R1 - R2. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |